Icatibant 30 MG/3 ML syringe 3ML
Ended Awarded
- Contract number
- SPE2DR26FA5ES
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $56,757
Award facts
- Contract value 100% obligated
- $56,757.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $56,757 delivery order to Amerisourcebergen Drug Corp on July 29, 2026, on a firm fixed-price basis for ICATIBANT 30 MG/3 ML syringes (3 mL), with ultimate completion on July 30, 2026. The order was issued with no set-aside. Place of performance is Conshohocken, PA 19428. The prime holds no SBA certifications.
Quick answers
Who was awarded contract SPE2DR26FA5ES?
SPE2DR26FA5ES was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2026.
How much is contract SPE2DR26FA5ES worth?
The government has obligated $56,757 on SPE2DR26FA5ES.
Is contract SPE2DR26FA5ES an order under another contract?
Yes. SPE2DR26FA5ES is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA5ES competed?
The extent of competition for SPE2DR26FA5ES was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award